Furthermore, hsCRP activates the nuclear factor-κB (NF-κB) pathway, inhibits insulin signalling, and promotes the secretion of pro-inflammatory factors by adipocytes, exacerbating glucose metabolism disorders [24]. Here, INS is linked to metabolic process.